Mekonos is creating a proprietary cell-engineering platform, using scalable silicon technology, for hyper-precise ex vivo delivery of molecules into any type of cell.
Location: United States, California, San Francisco
Total raised: $29.6M
Investors 9
Funding Rounds 2
| Date | Series | Amount | Investors |
| 10.11.2021 | Series A | $25M | - |
| 04.12.2020 | - | $4.6M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 10.11.2021 | Mekonos closes an oversubscribed, Novartis-backed $25M Serie... | Mekonos continues to build critical infrastructure which can unlock personalized medicine at scale a... | reimagined... |
| 10.11.2021 | Mekonos Raises $25M in Series A Funding | Mekonos, a San Francisco CA-based biotech company transforming synthetic biology and personalized me... | finsmes.co... |
| 09.11.2021 | Biotech Startup Mekonos raises oversubscribed $25 million ro... | SAN FRANCISCO, Nov. 9, 2021 /PRNewswire/ -- Mekonos, a biotech company building the future of cell t... | marketscre... |
| 09.11.2021 | Mekonos, Inc. announced that it has received $25 million in ... | On November 9, 2021, Mekonos, Inc. closed the transaction. The company has raised $25,000,000 in the... | marketscre... |
| 09.11.2021 | TDK Ventures backs MEMS-based genome editing tools company, ... | SAN JOSE, Calif. , Nov. 9, 2021 /PRNewswire/ -- TDK Corporation (TSE: 6762) announced today that sub... | marketscre... |
| 09.11.2021 | Mekonos Raises $25M Series A Round | SAN FRANCISCO, CA, Mekonos, a biotech company building the future of cell therapies on a chip, has... | vcnewsdail... |
| 09.11.2021 | Mekonos closes Novartis-backed $25M series A for cell engine... | Many of the rarest and hardest-to-treat diseases are caused by a single defect in a specific gene, m... | fiercebiot... |
| 04.12.2020 | Mekonos Raises $4.6M in Funding | Mekonos, a San Francisco, CA-based biotech company launching a system-on-a-chip (SoC) for targeted e... | finsmes.co... |
| 26.11.2020 | Mekonos raises $4.6M for its gene engineering platform | Mekonos, a biotech company launching the first-of-its kind system-on-a-chip (SoC) for targeted ex vi... | crcmventur... |